Susan is ready for a new adventure after the Vertiflex™ procedure

Twelve years ago, Arizonan Susan McDowell, 73, began to experience back pain that interfered with her ability to hike, golf, ski or even walk.

Read more about Susan's story

Featured stories

After developing intense pain, a minimally invasive procedure got him feeling better and back on his bike again.

Roughly 1 in 10 Americans are at risk of developing a kidney stone. Learn how a procedure called ureteroscopy can help.

How can leaders grow a team culture rooted in equity and inclusion? Meghan Scanlon shares some her own learnings.

Read more stories

Press releases
Feb 13, 2023

Boston Scientific Corporation (NYSE: BSX) will participate in Citi's 2023 Healthcare Services, MedTech, Tools & HCIT Conference on Wednesday, March 1, 2023. Dan Brennan, executive vice president...

Feb 3, 2023

New technology designed to help inform real-time clinical decisions during kidney stone procedures MARLBOROUGH, Mass., Feb. 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today...

Feb 1, 2023

Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on an operational1 basis and...

Read more press releases

In the news
Dec 16, 2023
Women Inc.
If you’re looking to advance your career, Mary Beth Moynihan, senior vice president of market access and chief marketing officer, has three words for you: “You’re worth it.”
Feb 15, 2023
Boston Scientific’s new global chief medical officer is already well-known in cardiovascular device space circles. Dr. Ken Stein joined Boston Scientific in 2009 as SVP and chief medical officer of its Rhythm Management business. He became chief medical officer for the entire company on Feb. 13.
Feb 13, 2023
Clinical trials are an early step in device and therapy development which have significant impact on the types of products available to patients. Boston Scientific leaders share how the company is working to advance diversity in medical research.
Feb 12, 2023
The Boston Globe
Trevor Boylston had transitioned from female to male a decade before he started working at Boston Scientific. He shares reflections on how navigating the world of work can be enormously challenging for members of the transgender community and how he got involved in the company’s LGBTQ resource group.

Read more news

2021 Performance Report

When science, humanity and purpose connect, lives can be transformed

View the Report

Sign up to receive our press releases via email

Business and enterprise contacts for journalists

Imagery and other resources